Zhejiang Nhu Co Ltd

SHE:002001 China Drug Manufacturers - Specialty & Generic
Market Cap
$14.78 Billion
CN¥108.43 Billion CNY
Market Cap Rank
#2167 Global
#127 in China
Share Price
CN¥35.28
Change (1 day)
-5.42%
52-Week Range
CN¥19.55 - CN¥39.30
All Time High
CN¥69.69
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Zhejiang NHU Company Ltd. engages in the production and sale of nutrition, flavor and fragrance, and new polymer materials in the People's Republic of China. The company offers nutrition products, such as vitamin E, vitamin H, vitamin A, vitamin C, methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, vitamin B5, vitamin B6, vitamin B12, serine, cystine, tryptophan, etc. for use in feed addi… Read more

Zhejiang Nhu Co Ltd (002001) - Net Assets

Latest net assets as of September 2025: CN¥32.36 Billion CNY

Based on the latest financial reports, Zhejiang Nhu Co Ltd (002001) has net assets worth CN¥32.36 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥45.09 Billion) and total liabilities (CN¥12.74 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥32.36 Billion
% of Total Assets 71.75%
Annual Growth Rate 22.94%
5-Year Change 51.75%
10-Year Change 317.47%
Growth Volatility 34.13

Zhejiang Nhu Co Ltd - Net Assets Trend (2001–2024)

This chart illustrates how Zhejiang Nhu Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Zhejiang Nhu Co Ltd (2001–2024)

The table below shows the annual net assets of Zhejiang Nhu Co Ltd from 2001 to 2024.

Year Net Assets Change
2024-12-31 CN¥29.45 Billion +18.16%
2023-12-31 CN¥24.92 Billion +5.31%
2022-12-31 CN¥23.66 Billion +8.23%
2021-12-31 CN¥21.86 Billion +12.68%
2020-12-31 CN¥19.40 Billion +14.81%
2019-12-31 CN¥16.90 Billion +4.23%
2018-12-31 CN¥16.22 Billion +15.85%
2017-12-31 CN¥14.00 Billion +73.00%
2016-12-31 CN¥8.09 Billion +14.70%
2015-12-31 CN¥7.05 Billion +0.54%
2014-12-31 CN¥7.02 Billion +6.77%
2013-12-31 CN¥6.57 Billion +8.56%
2012-12-31 CN¥6.05 Billion +7.40%
2011-12-31 CN¥5.64 Billion +16.33%
2010-12-31 CN¥4.84 Billion +62.57%
2009-12-31 CN¥2.98 Billion +54.14%
2008-12-31 CN¥1.93 Billion +124.45%
2007-12-31 CN¥861.32 Million +8.42%
2006-12-31 CN¥794.40 Million -0.16%
2005-12-31 CN¥795.65 Million +4.62%
2004-12-31 CN¥760.54 Million +113.19%
2003-12-31 CN¥356.74 Million +14.74%
2002-12-31 CN¥310.91 Million +22.06%
2001-12-31 CN¥254.72 Million --

Equity Component Analysis

This analysis shows how different components contribute to Zhejiang Nhu Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 18679.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥21.38 Billion 72.89%
Common Stock CN¥3.07 Billion 10.48%
Other Comprehensive Income CN¥2.02 Billion 6.89%
Other Components CN¥2.85 Billion 9.73%
Total Equity CN¥29.32 Billion 100.00%

Zhejiang Nhu Co Ltd Competitors by Market Cap

The table below lists competitors of Zhejiang Nhu Co Ltd ranked by their market capitalization.

Company Market Cap
REXFORD IND.REALTY DL-01
F:3I0
 		$7.07 Billion
Piotech Inc. A
SHG:688072
 		$7.08 Billion
Want Want China Holdings Ltd
PINK:WWNTY
 		$7.08 Billion
Ingredion Incorporated
NYSE:INGR
 		$7.08 Billion
Mowi ASA
PINK:MNHVF
 		$7.07 Billion
Medibank Private Ltd
AU:MPL
 		$7.06 Billion
Zalando SE
OTCGREY:ZLDSF
 		$7.06 Billion
Amdocs Ltd
NASDAQ:DOX
 		$7.05 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhejiang Nhu Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 24,804,662,320 to 29,324,997,728, a change of 4,520,335,408 (18.2%).
  • Net income of 5,868,545,992 contributed positively to equity growth.
  • Dividend payments of 1,663,409,238 reduced retained earnings.
  • Other comprehensive income increased equity by 33,222,839.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥5.87 Billion +20.01%
Dividends Paid CN¥1.66 Billion -5.67%
Other Comprehensive Income CN¥33.22 Million +0.11%
Other Changes CN¥281.98 Million +0.96%
Total Change CN¥- 18.22%

Book Value vs Market Value Analysis

This analysis compares Zhejiang Nhu Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.70x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 318.62x to 3.70x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-12-31 CN¥0.11 CN¥35.28 x
2002-12-31 CN¥0.14 CN¥35.28 x
2003-12-31 CN¥0.16 CN¥35.28 x
2004-12-31 CN¥0.36 CN¥35.28 x
2005-12-31 CN¥0.38 CN¥35.28 x
2006-12-31 CN¥0.31 CN¥35.28 x
2007-12-31 CN¥0.35 CN¥35.28 x
2008-12-31 CN¥0.75 CN¥35.28 x
2009-12-31 CN¥1.63 CN¥35.28 x
2010-12-31 CN¥1.93 CN¥35.28 x
2011-12-31 CN¥2.11 CN¥35.28 x
2012-12-31 CN¥2.27 CN¥35.28 x
2013-12-31 CN¥2.46 CN¥35.28 x
2014-12-31 CN¥2.62 CN¥35.28 x
2015-12-31 CN¥2.65 CN¥35.28 x
2016-12-31 CN¥3.01 CN¥35.28 x
2017-12-31 CN¥5.23 CN¥35.28 x
2018-12-31 CN¥5.22 CN¥35.28 x
2019-12-31 CN¥5.45 CN¥35.28 x
2020-12-31 CN¥6.25 CN¥35.28 x
2021-12-31 CN¥7.08 CN¥35.28 x
2022-12-31 CN¥7.67 CN¥35.28 x
2023-12-31 CN¥7.98 CN¥35.28 x
2024-12-31 CN¥9.54 CN¥35.28 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhejiang Nhu Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 20.01%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 27.16%
  • • Asset Turnover: 0.50x
  • • Equity Multiplier: 1.47x
  • Recent ROE (20.01%) is above the historical average (18.09%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 19.09% 7.84% 0.63x 3.85x CN¥20.14 Million
2002 18.36% 7.36% 0.82x 3.05x CN¥23.16 Million
2003 21.58% 7.28% 0.90x 3.28x CN¥37.17 Million
2004 9.96% 6.40% 0.71x 2.19x CN¥-282.77K
2005 8.10% 4.87% 0.63x 2.63x CN¥-14.38 Million
2006 4.44% 2.12% 0.66x 3.15x CN¥-42.31 Million
2007 9.25% 4.41% 0.69x 3.04x CN¥-6.24 Million
2008 75.05% 41.48% 0.89x 2.03x CN¥1.19 Billion
2009 36.61% 35.14% 0.69x 1.51x CN¥740.20 Million
2010 22.75% 31.93% 0.56x 1.27x CN¥616.49 Million
2011 20.66% 30.85% 0.53x 1.27x CN¥600.87 Million
2012 14.05% 23.41% 0.46x 1.29x CN¥244.94 Million
2013 13.43% 20.82% 0.50x 1.30x CN¥225.06 Million
2014 11.52% 19.40% 0.46x 1.30x CN¥106.52 Million
2015 5.70% 10.52% 0.39x 1.38x CN¥-302.77 Million
2016 14.92% 25.61% 0.41x 1.42x CN¥396.38 Million
2017 12.21% 27.34% 0.34x 1.30x CN¥308.72 Million
2018 19.04% 35.46% 0.40x 1.36x CN¥1.46 Billion
2019 12.85% 28.27% 0.27x 1.69x CN¥480.47 Million
2020 18.43% 34.55% 0.33x 1.60x CN¥1.63 Billion
2021 19.98% 29.20% 0.43x 1.59x CN¥2.18 Billion
2022 15.36% 22.72% 0.42x 1.62x CN¥1.26 Billion
2023 10.90% 17.89% 0.39x 1.58x CN¥223.77 Million
2024 20.01% 27.16% 0.50x 1.47x CN¥2.94 Billion

Industry Comparison

This section compares Zhejiang Nhu Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Zhejiang Nhu Co Ltd (002001) CN¥32.36 Billion 19.09% 0.39x $7.07 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million